By Counterforce Health Team in Elfabrio (pegunigalsidase alfa-iwxj) —

How to Get Elfabrio (pegunigalsidase alfa-iwxj) Covered by Cigna in New Jersey: Complete PA Guide and Appeal Scripts

Answer Box: Get Elfabrio Covered by Cigna in New Jersey

Elfabrio (pegunigalsidase alfa-iwxj) requires prior authorization from Cigna and is available through Accredo specialty pharmacy. To get coverage in New Jersey: 1) Your specialist submits Cigna's Elfabrio PA form with confirmed Fabry disease diagnosis, 2) Order through Accredo (NCPDP 4436920), and 3) If denied, appeal internally within 180 days, then use New Jersey's Independent Health Care Appeals Program (IHCAP) for external review. Start today by confirming your diagnosis documentation and contacting your prescriber.

Table of Contents

What Drives Elfabrio Costs

Elfabrio (pegunigalsidase alfa-iwxj) is a specialty enzyme replacement therapy for Fabry disease with significant cost considerations. Understanding your benefit design helps you navigate coverage effectively.

Formulary Tier: Elfabrio appears on Cigna's 2026 Express Scripts National Preferred Formulary as a specialty drug, typically placing it on Tier 4 with higher copays or coinsurance (often 25-40% of drug cost).

Prior Authorization Required: All Cigna plans require PA for Elfabrio per Cigna Policy IP0570, effective September 1, 2025.

Site of Care Impact: Home infusion through pharmacy benefit typically costs less than clinic administration through medical benefit, which includes facility fees and may be subject to deductibles.

Tip: Cash prices show estimates around $4,245 per vial via GoodRx, but insurance negotiated rates vary significantly.

Benefit Investigation: What to Ask

Before starting the approval process, gather this information from Cigna:

Call Cigna Customer Service (number on your insurance card):

  • "Is Elfabrio covered on my formulary and what tier?"
  • "What's my specialty drug copay or coinsurance?"
  • "Do I have a specialty drug deductible?"
  • "Is prior authorization required?"
  • "Which specialty pharmacy must I use?"
  • "Is home infusion covered?"

Document These Details:

  • Policy/member ID number
  • Group number (if employer plan)
  • Plan year (benefits may change annually)
  • Specialty pharmacy network requirements
  • Any step therapy requirements

Assistance Options

Manufacturer Support

Chiesi Total Care provides copay assistance for commercial insurance patients. The program covers:

  • Copay assistance for eligible patients
  • Infusion copay assistance
  • Prior authorization support
  • Benefit verification and appeals assistance

Eligibility: Commercial insurance only (excludes Medicare, Medicaid, VA, TRICARE). Contact Chiesi Total Care at 1-833-670-6464 or enroll online.

Foundation Grants

Fabry Assist by FSIG: Provides financial grants for transportation, diagnostic testing, medical bills, and Fabry-related expenses. Apply at fabry.org/programs.

NORD's Fabry Disease Premium Copay Assistance Program: Annual financial support for confirmed Fabry patients meeting income criteria. Apply at rarediseases.org.

New Jersey State Programs

PAAD (Pharmaceutical Assistance to the Aged and Disabled): State-funded prescription help for eligible low-income seniors and disabled residents. Check eligibility at nj.gov/humanservices.

Step-by-Step: Fastest Path to Approval

1. Confirm Diagnosis Documentation

Who: Patient and prescriber
What: Genetic testing showing GLA mutation OR enzyme assay showing <4% α-galactosidase A activity
Timeline: Before PA submission
Source: Cigna Policy IP0570

2. Specialist Prescriber Verification

Who: Prescriber
What: Must be geneticist, endocrinologist, metabolic disorder specialist, or lysosomal storage specialist
Timeline: Required for PA approval

3. Complete PA Form

Who: Prescriber
What: Cigna Elfabrio PA form
How: Fax to 855-840-1678 or submit via CoverMyMeds
Timeline: 5 business days for standard review

4. Order Through Accredo

Who: Prescriber
What: E-prescribe to NCPDP 4436920 or fax 888-302-1028
Contact: 866-759-1557 for verbal orders
Timeline: After PA approval

5. Monitor Approval Status

Who: Patient
What: Check myCigna app or call customer service
Timeline: Follow up if no response in 5 business days

Common Denial Reasons & Fixes

Denial Reason How to Overturn
Insufficient diagnosis documentation Submit genetic test results or enzyme assay from certified lab showing <4% activity
Not prescribed by specialist Provide prescriber credentials showing specialization in genetics, endocrinology, or metabolic disorders
Not medically necessary Include clinical rationale letter citing FDA labeling and patient symptoms
Site of care restrictions Request home infusion if clinically appropriate; justify clinic need if required
Concurrent therapy concerns Confirm no concurrent use with other enzyme replacement therapies
Clinician Corner: Medical necessity letters should include confirmed diagnosis method, symptom progression, treatment goals, and references to FDA labeling and clinical guidelines.

Appeals Playbook for Cigna in New Jersey

Internal Appeals (180-Day Window)

Level 1: Submit via Cigna member portal or mail within 180 days of denial

  • Include original denial letter
  • Additional medical documentation
  • Prescriber letter addressing denial reasons
  • Timeline: 30 days for standard, 72 hours for urgent

Level 2: If Level 1 denied, request second internal review

  • Same documentation requirements
  • Timeline: 30 days for decision

External Review: New Jersey IHCAP

After completing internal appeals, New Jersey residents can use the Independent Health Care Appeals Program.

Process:

  1. Submit external appeal directly to Maximus Federal Services within 4 months (180 days) of final internal denial
  2. Maximus conducts preliminary review (5 business days)
  3. Physician panel reviews case (45 days for standard, expedited available)
  4. Decision is binding on Cigna

Contact: IHCAP hotline at 1-888-393-1062 or NJ Department of Banking and Insurance Consumer Hotline at 1-800-446-7467

Note: About half of external appeals nationwide favor consumers, especially for rare disease treatments with strong clinical evidence.

Pharmacy Choice and Site of Care

Accredo Specialty Pharmacy is Cigna's nationally preferred provider for Elfabrio. Benefits include:

  • 24/7 pharmacist and nurse support
  • Free shipping including refrigerated delivery
  • Refill reminders via myCigna app
  • Copay assistance coordination

Site of Care Options (must specify on PA form):

  • Home infusion: Often lower cost through pharmacy benefit
  • Physician's office: May have higher facility fees
  • Hospital outpatient: Typically highest cost option

Cigna's "least intensive medically appropriate setting" policy may require justification for clinic-based infusion if home is viable.

Renewal Budgeting

Annual Considerations:

  • Formulary changes (review each January)
  • Benefit design modifications
  • Copay assistance program renewals
  • Foundation grant reapplications

PA Renewal: Cigna typically approves Elfabrio for 1-year periods. Prepare renewal documentation 30-60 days before expiration.

FAQ

Q: How long does Cigna PA take in New Jersey?
A: Standard review is 5 business days. Urgent requests (call 800-882-4462) are processed within 72 hours.

Q: What if Elfabrio is non-formulary on my plan?
A: Request a formulary exception with medical necessity documentation. Include clinical rationale and specialist recommendation.

Q: Can I request an expedited appeal?
A: Yes, if delay would cause serious harm to your health. Contact Cigna immediately and specify urgent review needed.

Q: Does step therapy apply to Elfabrio?
A: Cigna doesn't specify mandatory step therapy to other Fabry treatments, but may question appropriateness of Elfabrio vs. alternatives like Galafold if your GLA mutation is amenable.

Q: What happens if I move out of New Jersey?
A: External review rights vary by state. Contact your new state's insurance department for appeal processes.

Q: Can my doctor file the external appeal for me?
A: Yes, New Jersey allows providers to file external appeals on behalf of patients with written consent.

From our advocates: We've seen cases where patients initially denied for Elfabrio succeeded on appeal by submitting comprehensive genetic testing results and detailed symptom documentation. The key is addressing the specific denial reason with targeted clinical evidence—generic letters rarely succeed, but personalized appeals with strong specialist support often do.

About Counterforce Health: Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into successful appeals. Our platform analyzes denial letters and creates evidence-backed rebuttals aligned to each plan's specific requirements, significantly improving approval rates for specialty medications like Elfabrio.

When facing a complex prior authorization or appeal, having the right documentation and approach makes all the difference. Counterforce Health's targeted appeal process has helped numerous patients access critical treatments by presenting compelling, policy-specific arguments that address payers' exact concerns.

Sources & Further Reading

Disclaimer: This information is for educational purposes and does not constitute medical or legal advice. Insurance coverage varies by plan and individual circumstances. Always consult your healthcare provider for medical decisions and your insurance company for coverage details. For appeals assistance in New Jersey, contact the NJ Department of Banking and Insurance at 1-800-446-7467.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.